Ronald L. Koretz, MD
Koretz RL. In nonvalvular AF, DOAC-related risk for GI bleeding was lower with apixaban than dabigatran or rivaroxaban. Ann Intern Med. 2017;167:JC21. doi: 10.7326/ACPJC-2017-167-4-021
Download citation file:
Published: Ann Intern Med. 2017;167(4):JC21.
Cardiology, Gastroenterology/Hepatology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use